Media Capital Technologies (MCT) and The Horror Section will fully finance and produce “Ice Cream Man,” Eli Roth’s new horror film. Roth, a master of the genre whose work includes the ...

Despite beating on its earnings Thursday, pharma giant Eli Lilly (LLY) suffered a nearly 12% loss in its stock, losing more than $90 billion in market cap in a single day. "We think the market ...

Here’s an idea for the next episode of “The Eli Manning Show.” The former quarterback visits various investors and tries to pool enough money to buy a minority ownership stake in the Giants.

Eli Manning has his sights on the Giants. The two-time Super Bowl winning quarterback is putting together an ownership group to bid for a piece of the Giants, according to Bloomberg. The report ...

Giants legend Eli Manning could soon own a minority stake of his old team. According to a report from Bloomberg, the former quarterback is putting together an investment group to bid for a piece ...

HSBC cut its rating to "reduce" from "buy," and slashed its price objective Eli Lilly And Co (NYSE:LLY) stock is 1.6% lower to trade at $870.31 at last check, after a rare double downgrade from ...

Pharmaceutical company Eli Lilly announced promising clinical trial results this week for a daily pill to treat obesity and diabetes. Besides the good news of minimal side effects and impressive ...

Will Jaxson Dart be the Giants’ next Eli Manning, after six mostly brutal seasons of Daniel Jones? Maybe. And if the second time is the charm for the Giants in their post-Manning years ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced success Thursday of its Phase 3 clinical trial for a once-daily GLP-1 pill — an oral form of the blockbuster medication used for ...

Eli Lilly stock surged as much as 17% after positive phase-three trial data came out for orforglipron. It found orforglipron, a GLP-1 weight-loss pill, led to significant weight and A1C reductions ...

Eli Roth‘s The Horror Section has acquired “Jimmy and Stiggs,” marking the horror company’s first major deal since launching earlier this month, Variety can exclusively report. Directed ...

It's hard to argue with the kinds of results Eli Lilly (NYSE: LLY) has produced over the past five years. The company has been one of the best-performing pharmaceutical giants, with its shares ...